Global Growth Strategy

Sartorius’ 2025 annual report shows the company’s continued global footprint, with around 60 production and sales sites worldwide and approximately €3.5 billion in sales revenue for the life science group. The workforce of over 14,000 employees supports two core divisions: Lab Products & Services, which supplies laboratory instruments and consumables, and Bioprocess Solutions, which delivers single‑use systems for biotech drugs, vaccines, and cell and gene therapies. The financial calendar for the next year notes the Annual General Meeting on March 26 2026 and quarterly results releases scheduled for April, July, and October 2026. The report underscores Sartorius’ strategy of adding complementary technologies through acquisitions to drive growth and innovation.